Aurinia Pharmaceuticals Inc (AUPH)

SG&A Expense Growth

6.71%

Quarterly · Period ending:

AUPH logo

AUPH SG&A Expense Growth

Latest reported6.71%
AUPH Quarterly SG&A Growth (QoQ) (0.00% → 6.71%)
High-resolution chart · PNG

AUPH sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aurinia Pharmaceuticals Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
11.0662%
86.8173%
-27.626%
35.5815%
-1.4233%
74.1403%
-1.3423%
-23.2701%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.